Concourse Financial Group Securities, Inc. Relay Therapeutics, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q1 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding RLAY
# of Institutions
223Shares Held
164MCall Options Held
153KPut Options Held
49.2K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$98.5 Million0.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$42.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.8MShares$38.2 Million0.07% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$37.2 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.1MShares$32.1 Million2.79% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $424M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...